China Universal Asset Management Co., Ltd. Day One Biopharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,817 shares of DAWN stock, worth $230,561. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,817
Previous 16,817
-0.0%
Holding current value
$230,561
Previous $278,000
0.36%
% of portfolio
0.04%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.2 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$65.5 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$52.2 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$39.7 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...